Price target upside
DiaMedica Therapeutics Price Target Upside or Downside
DMAC price target upside based on the current price and analyst average.
Direct answer
DiaMedica Therapeutics's analyst target implies +137.4%.
The average target is $15.50 compared with a recorded current price of $6.53.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 4, 2026.
Verified data
- Current price
- $6.53
- Average price target
- $15.50
- High price target
- $25.00
- Low price target
- $11.00
- Target upside
- +137.4%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 4, 2026
- Valid through
- August 11, 2026